Comparative Antidiabetic Potential Assessment of Herbal Formulation of Gymnemic Acid and Curcumin
Abstract
Standardization of polyherbal formulations with respect to bioactive phytocompounds is the need of the time for registration and marketing authorization in developed countries. This has prompted to prepare and evaluate a standardized bioactive phyotcompounds conintaining formulation. The study aims at development and screening of a standardized antidiabetic suspension containing active isolated phytoconstituents targeting better therapeutic effect with reduced bioburden. Suspension of isolated gymnemic acid and curcumin (GCS) was prepared, evaluated and authenticated by TLC and HPTLC. Antidiabetic efficacy of GCS was screened against alloxan induced diabetes on rats following 28 days of treatment comparative to Hyponidd tablet and Madhumehari granules. Body weight, relative organ weight, blood glucose, cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL) and very low density lipoprotein (VLDL) level was measured. The formulation having pH 6.0, refractive index 1.41 and 45.58 mg/ml total solid content showed high alcohol and water soluble extractive value. The GCS treatment normalized liver and kidney weight, decreased body weight gain, TC, TG, LDL and VLDL level along with an increase in HDL level. Study outcome signifies similar antidiabetic potential of standardized formulation GCS compared to marketed Polyherbal formulation with antihyperlipidemic activity signifying as a promising natural and safe remedy for the prevention of diabetic complications.
Keywords:
Gymnemic acid, Curcumin, Polyherbal formulation, antidiabetic, antihyperlipidemic.DOI
https://doi.org/10.25004/IJPSDR.2019.110305References
European Medicines Agency. Herbal medicinal products. https://www.ema.europa.eu/en/human-regulatory/herbal-medicinal-products.
Sahoo N, Manchikanti P. Drug Regulation and Commercialization: An Indian Industry. Journal of Alternative and Complementary Medicine. 2013; 19(12): 957-963. DOI: 10.1089/acm.2012.0275.
Anonymous. Diabetes is India's fastest growing disease: 72 million cases recorded in 2017, figure expected to nearly double by 2025. 2018. Available at: http://www.firstpost.com/india/diabetes-is-indias-fastest-growing-disease-72-million-cases-recorded-in-2017-figure-expected-to-nearly-double-by-2025-4435203.html.
Gupta R, Bajpai GK, Johri S, Saxena AM. An overview of Indian novel traditional medicinal plants with antidiabetic potentials. African Journal of Traditional, Complementary and Alternative Medicines. 2008; 5(1): 1-17.
Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. Indian herbs and herbal drugs used for the treatment of diabetes. Journal of Clinical Biochemistry and Nutrition. 2007; 40(3): 163-173. DOI: 10.3164/jcbn.40.163.
Subramani P, Gan ST, Dhanaraj SA. Polyherbal formulation: Concept of Ayurveda. Pharmacognosy Review. 2014; 8(16): 73-80. DOI: 10.4103/0973-7847.134229
Sharma AK, Gaurav SS, Balkrishna A. A rapid and simple scheme for the standardization of polyherbal drugs. International Journal of Green Pharmacy. 2009; 3(2): 134-140.
Kumar P, Rani S, Arunjyothi B, Chakrapani P, Rojarani A. Evaluation of antidiabetic activity of Gymnema sylvestre and Andrographis paniculata in streptozotocin induced diabetic Rats. International Journal of Pharmacognosy and Phytochemistry Research. 2017; 9(1): 22-25. DOI: 10.25258/ijpapr.v9i1.8035.
Mohammed A, Wudil AM, Alhassan AJ, Imam AA, Muhammad IU, Idi A. Hypoglycemic activity of Curcuma longa Linn root extracts on alloxan induced diabetic rats. Haya: Saudi Journal of Life Science. 2017; 2(2): 43-49. DOI: 10.21276/haya.2017.2.2.4 43.
Chowdhary F, Rasool MH. Isolation and characterization of Gymnemic acid from indigenous Gymnema sylvestre. Journal of Applied Pharmacy. 2010; 3(2): 60-65. DOI: 10.21065/19204159.2.60.
Anonymous. Master document of Gymnema sylvestris. Natural Remedy Bangalore. 2010. Available at: https://www.naturalremedy.com/products/human.
Kokate CK, Purohit AP, Gokhale SB. A Textbook of Pharmacognosy. 39th Edn., Nirali prakashan, Pune. 2004; pp. 134-135. ISBN No: 9788185790152.
WHO. Quality control methods for medicinal plant material. Organization Mondiale De La Sante, Geneva. 1998. http://whqlibdoc.who.int/publications/1998/9241545100.pdf.
The Ayurvedic Pharmacopoeia of India. Government of India Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha & Homoeopathy (AYUSH). Part I, vol. 51th Edn., The Controller of Publications, New Delhi. 2006; pp. 143-144. ISBN No: 8190115138/9788190115131.
Malik JK, Manvi FV, Alagawadi KR, Noolvi M. Evaluation of anti-inflammatory activity of Gymnema sylvestre leaves extract in Rats. International Journal of Green Pharmacy. 2008; 2: 114-115. DOI: http://dx.doi.org/10.22377/ijgp.v2i2.42
Mall GK, Mishra PK, Prakash V. Antidiabetic and hypolipidemic activity of G. sylvestre in alloxan induced diabetes. Global Journal of Biotechnology and Biochemistry. 2009; 4(1): 37-42.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972; 18(6): 499-502.
Dwivedi C, Daspaul S. Antidiabetic herbal drugs and polyherbal formulation used for diabetes: A review. Journal of Phytopharmacology. 2013; 2(3): 44-51.
Miccoli R, Penno G, Del Parto S. Multidrug treatment of type 2 diabetes: A challenge for compliance. Diabetes Care. 2011; 34(Suppl 2): S231-S235. DOI: 10.2337/dc11-s235.
Kim HJ, Hong SH, Chang SH, Kim S, Lee AY, Jang Y, Davaadamdin O, Yu KN, Kim JE, Cho MH. Effects of feeding a diet containing Gymnema sylvestre extract: Attenuating progression of obesity in C57BL/6J mice. Asian Pacific Journal Tropical Medical. 2016; 9(5): 437-444.
El Shafey AAM, El-Ezabi MM, Seliem MME, Ouda HHM, Ibrahim DS. Effect of Gymnema sylvestre R. Br. leaves extract on certain physiological parameters of diabetic rats. Journal of King Saud Univerity of Science. 2013; 25(2): 135-141.
Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan AP, Arumugam S, Suzuki K. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. Molecular Nutrition and Food Research. 2011; 55(11): 1655-1665. DOI: 10.1002/mnfr.201100080.
Seo KI, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM, Lee MK. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Molecular Nutrition and Food Research. 2008; 52(9): 995-1004. DOI: 10.1002/mnfr.200700184.
Eleazu CO, Iroaganachi M, Okafor PN, Ijeh II, Eleazu KC. Ameliorative potentials of ginger (Z. officinale Roscoe) on relative organ weights in streptozotocin induced diabetic rats. International Journal of Biomedical Science. 2013; 9(2): 82-90.
Vijayaraghavan K. Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Disease. 2010; 9: 144. DOI: 10.1186/1476-511X-9-144
Ye J. Mechanisms of insulin resistance in obesity. Frontiers in Medicine. 2013; 7(1): 14-24. DOI: 10.1007/s11684-013-0262-6
Peterson KF, Dufour S, Savage DB, Bliz S, Soloman G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Khan BB, Papademetris X, Rothman DL, Shulman GI. The role of skeletal muscles insulin resistance in the pathogenisis of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104: 12587-12594. DOI: 10.1073/pnas.0705408104.
Published
Abstract Display: 561 
PDF Downloads: 973 
